Jincheng Qiao

Mr. Jincheng Qiao


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JQJincheng Qiao
Jincheng Qiao
ZYZhengchen Yu
Zhengchen Yu
HZHan Zhou
Han Zhou
WWWankun Wang
Wankun Wang
HWHao Wu
Hao Wu
JYJun Ye
Jun Ye
The pentose phosphate pathway (PPP), traditionally recognized for its role in generating nicotinamide adenine dinucleotide phosphate (NADPH) and ribose-5-phosphate (R5P), has emerged as a critical metabolic hub with involvements in various gastrointestinal (GI) cancers. The PPP plays crucial roles in the initiation, development, and tumor microenvironment (TME) of GI cancers by modulating redox homeostasis and providing precursors for nucleotide biosynthesis. Targeting PPP enzymes and their regulatory axis has been a potential strategy in anti-GI cancer therapies. In this review, we summarize the regulatory mechanisms of PPP enzymes, elucidate the relationships between the PPP and TME’s elements, and discuss the therapeutic potential of targeting the PPP in GI cancers.

13 November 2020 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
YKYuanbo Kang
Yuanbo Kang
WHWeihan He
Weihan He
CRCaiping Ren
Caiping Ren
JQJincheng Qiao
Jincheng Qiao
QGQiuyong Guo
Qiuyong Guo
LWLei Wang
Lei Wang
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

22 December 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
WWWankun Wang
Wankun Wang
XWXujin Wang
Xujin Wang
GCGang Che
Gang Che
JQJincheng Qiao
Jincheng Qiao
ZCZhendong Chen
Zhendong Chen
JLJian Liu
Jian Liu
(1) Background: This study aimed to establish a nomogram model for predicting the overall survival (OS) of medullary thyroid carcinoma (MTC) patients based on the Surveillance, Epidemiology, and End Results (SEER) database. (2) Methods: Patients with MTC in the SEER database from 2004 to 2015 were included and divided into a modeling group and an internal validation group. We also selected MTC patients from our center from 2007 to 2019 to establish an external validation group. Univariate and multivariate Cox regression analyses were used to screen for significant independent variables and to establish a nomogram model. Kaplan–Meier (K-M) curves were plotted to evaluate the influence of the predictors. The C-indexes, areas under the curves (AUCs), and calibration curves were plotted to validate the predictive effect of the model. (3) Results: A total of 1981 MTC patients from the SEER database and 85 MTC patients from our center were included. The univariate and multivariate Cox regression analyses showed that age, tumor size, N stage, and M stage were significant factors, and a nomogram model was established. The C-index of the modeling group was 0.792, and the AUCs were 0.811, 0.825, and 0.824. The C-index of the internal validation group was 0.793, and the AUCs were 0.847, 0.846, and 0.796. The C-index of the external validation group was 0.871, and the AUCs were 0.911 and 0.827. The calibration curves indicated that the prediction ability was reliable. (4) Conclusions: A nomogram model based on age, tumor size, N stage, and M stage was able to predict the OS of MTC patients.